Abstract:Abstract Background Inflammatory bowel disease(IBD)is chronic relapsing and remitting disease of the gastrointestinal tract. Although the precise aetiology and pathogenesis of IBD remains elusive, epidemiological data conclusively point to be attributed to an aberrant immune response against environmental factors such as the gut microbiota in a genetically susceptible host. The bacterial microbiota plays a major role in human physiology and pathogenesis of IBD. The Fungi are often ignored in studies. Although the role of fungi has been suggested in pathogenesis of IBD, the available data are scarce. The aim of our study was to analyse and compare the faecal fungal microbiota in patients with IBD and healthy subjects (HS). Methods Our study evaluated fungal composition of the faecal microbiota of 66 patients with CD and 38 patients with UC diagnosed in West China Hospital and 39 HS by ITS2 sequencing. The Qiime pipeline was used to assess composition and diversity. Using LEfSe observed differential fungal composition between subjects. Results The faecal fungal microbiota was dominated by two phyla, basidiomycetes and ascomycetes in both IBD and HS. We observed that fungal microbiota was skewed in IBD, with an decreased basidiomycota/ascomycota ratio, a decreased proportion of Aspergillus and Saccharomyces and an increased proportion of Exophiala. Polythrincium, clonostachys, Candida compared with HS. Using LEfSe, we observed several differential fungal composition in different subject. Exophial a (p = 0.02), Agaricales (p = 0.02)species were overrepresented in UC, whereas Bulleribasidiaceae (p = 0.01), Ustilaginaceae (p = 0.007), Ustilaginales (p = 0. 007),Ustilaginomycetes (p = 0.007)species were overrepresented in HS. We then directly compared the fungal composition between subgroup of CD and UC, we observed Eurotiales(p = 0.007), Aspergillus(p = 0.025), Thermoascus(p = 0.04)species were overrepresented in UC-remission. Ascomycota (p = 0.008) and Didymellaceae (p = 0.02)species were associated with CD-remission, whereas Saccharomyces (p = 0.03) and Xylariaceae (p = 0.006) species were associated with CD-flare. There was no significant difference in fungal Alpha diversity between IBD and HS. Beta diversity analysis showed that one subgroup of IBD samples segregated from HS whereas another subgroup overlapped with HS. Conclusion There was no significant change in fungal diversity in IBD. However, we observed fungal composition was skewed with decreased basidiomycota/ascomycota ratio on phyla level, particularly in IBD-flare group. The fungal composition was dominated by Aspergillus and Saccharomyces in HS, while the proportion of Exophiala, Polythrincium, Clonostachys, Candida was increased in IBD on genus level.

Review article: fungal alterations in inflammatory bowel diseases

Mucosal Immunity to Gut Fungi in Health and Inflammatory Bowel Disease

Effect of diet on the gut mycobiome and potential implications in inflammatory bowel disease

Fungal microbiome in inflammatory bowel disease: a critical assessment

Review article: fungal microbiota and digestive diseases

Fungal microbiota dysbiosis in IBD

An (Anti)-Inflammatory Microbiota: Defining the Role in Inflammatory Bowel Disease?

P842 Analysis of fungal microbiota dysbiosis in inflammatory bowel disease

Unveiling the overlooked fungi: the vital of gut fungi in inflammatory bowel disease and colorectal cancer

A comprehensive guide to assess gut mycobiome and its role in pathogenesis and treatment of inflammatory bowel disease

Specific changes of enteric mycobiota and virome in inflammatory bowel disease

P145 Phagocyte responses to gut-derived C. albicans are modified in inflammatory bowel disease

Gut microbial metabolome in inflammatory bowel disease: From association to therapeutic perspectives

Dysbiosis of gut fungal microbiota is associated with mucosal inflammation in Crohn's disease.

Changes of the fungal microbiota in inflamed intestinal mucosa of the patients with Crohn's disease

Bacteria-derived short-chain fatty acids as potential regulators of fungal commensalism and pathogenesis

Changes in the composition of intestinal fungi and their role in mice with dextran sulfate sodium-induced colitis

Alterations in the mucosa-associated fungal microbiota in patients with ulcerative colitis

The gut microbes in inflammatory bowel disease: Future novel target option for pharmacotherapy

Alteration of Gut Microbiota in Inflammatory Bowel Disease (IBD): Cause or Consequence? IBD Treatment Targeting the Gut Microbiome